The Application of NMR for Drug Development and Manufacturing in a Good Manufacturing Practice Setting
At Almac, GMP regulations set by the Pharmaceutical regulatory bodies such as the FDA (Food and Drug Administration) and the MHRA (Medicine and Healthcare products Regulatory Authority) ensure that manufacturing processes and facilities are properly designed, monitored and controlled. The GMP environment guarantees the identity, strength, quality and purity of drug products. In this webinar, technical leader at Almac, Kerry Hughes, will discuss the application of NMR in the GMP setting to ensure continued high-quality performance of drug discovery, drug development and manufacturing workflows. The organization has two Bruker instruments for the whole spectrum of GMP activities, from the early phase of development through to the final commercial product, which could be anything from raw materials through to active pharmaceutical ingredients that are ready for release.
What to expect
The webinar will provide an overview of GMP and the convenience of applying NMR to the molecules the company is developing and using. NMR requires few set-up stages and the instruments are also open access, walk-up devices. Specific examples will be given of how NMR is applied to meet GMP regulations.
- The versatility, convenience and accessibility of NMR in a GMP setting
- NMR in a GMP environment requires qualification and controls to ensure continued high-quality performance.
- Applications include supplier qualification, method validation, the quantification of residual solvents and full structural elucidation of small molecules and peptides
- Bruker’s 400 AVANCE with QNP probe and 500 AVANCE NEO with prodigy cooled CryoProbe
Who should attend?
This webinar will appeal to people working in drug development, manufacture, quality control and quality assurance. It will also be of interest to those in non-pharmaceutical industries such as smaller businesses or universities who are looking to conform with GMP regulations.
Almac Group is an established, leading contract development and manufacturing organisation providing an extensive range of integrated services to over 600 pharmaceutical and biotech companies globally. Its Sciences Business Unit offers services including API development & manufacture, radiolabelling, biocatalysis solutions, peptides & protein technology, pre-formulation, solid state and analytical services. The privately owned, global organisation has grown organically for 50 years now employing in excess of 5,000 highly skilled personnel and has a strong reputation for innovation, quality and exceptional customer service. The Group is headquartered in Craigavon, Northern Ireland with additional operations based throughout Europe, US and Asia.